Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 3, 2006, Pages 182-187

  Chen, Po Liang ^a   Chen, Jiann Torng ^a   Lu, Da Wen ^a   Chen, Yo Chang ^b   Hsiao, Chih Hsien ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; COCAINE;

ADOLESCENT; ADULT; ANISOCORIA; APNEA; ARTICLE; BRADYCARDIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DENERVATION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HORNER SYNDROME; HUMAN; HYPEREMIA; HYPOTENSION; INFANT; LETHARGY; MALE; PEDIATRICS; PUPIL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLONIDINE; COCAINE; CROSS-OVER STUDIES; FEMALE; HORNER SYNDROME; HUMANS; INFANT; MALE; PUPIL;

EID: 33745895308     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.182     Document Type: Article

References (19)

1. Thompson, H.S., and Miller, N.R. Disorders of papillary function, accommodation, and lacrimation. In: Walsh, F.B., Hoyt, W.F. eds. Clinical Neuro-Ophthalmology. 5th ed. Baltimore: Williams & Wilkins, 1969:514-521.
2. Pilley, S.F.J., and Thompson, H.S. Pupillary "dilatation lag" in Horner syndrome. Br. J. Ophthalmol. 59:731-735, 1975.
3. Jeffery, A.R., Ellis, F.J., Repka, M.X., et al. Pediatric Horner syndrome. J. AAPOS 2:159-167, 1998.
4. Thompson, H.S. Diagnosing Horner syndrome. Trans. Sect. Ophthalmol. Am. Acad. Ophthalmol. Otolaryngol. 83:840-842, 1977.
5. Lepore, F.E. Diagnostic pharmacology of the pupil. Clin. Neuropharmacol. 8:27-37, 1985.
6. Van der Wiel, H.L., and Van Gijn, J. The diagnosis of Horner syndrome. Clin. Neurol. Neurosurgr. 90:103-108, 1988.
7. Morales, J., Brown, S.M., Abdul-Rahim, A.S., et al. Ocular effects of apraclonidine in Horner syndrome. Arch. Ophthalmol. 118:951-954, 2000.
8. Brown, S.M., Aouchiche, R., and Freedman, K.A. The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch. Ophthalmol. 121:1201-1203, 2003.
9. Bacal, D.A., and Manche, E.E. The role of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch. Ophthalmol. 122:276-279, 2004.
10. Weinstein, J.M., Zweifel, T.J., and Thompson, H.S. Congenital Horner syndrome. Arch. Ophthalmol. 98:1074-1078, 1980.
11. Kardon, R.H., Denison, C.E., Brown, C.K., et al. Critical evaluation of the cocaine test in the diagnosis of Horner syndrome. Arch. Ophthalmol. 108:384-387, 1990.
12. Miller, P.E., and Rhaesa, S.L. Effect of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats. Am. J. Vet. Res. 57:83-86, 1996.
13. Crosson, C.E., Heath, A.R., DeVies, G.W., et al. Pharmacological evidence for heterogeneity of ocular alpha-2 adrenoceptors. Curr. Eye Res. 11:963-970, 1992.
14. Van der Wiel, H.L., and Van Gijn, J. The diagnosis of Horner syndrome: Use and limitation of the cocaine test. J. Neuro. Sci. 73:311-316, 1986.
15. Gillum, W.N. Sympathetic stimulators and blockers. Ophthalmic Semin. 2:283-326, 1977.
16. Wilhelm, H., and Wilhelm, B. Clinical applications of pupillography. J. Neuro-Ophthalmol. 23:42-49, 2003.
17. Koc, F., Kavuncu, S., Kansu, T., et al. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br. J. Ophthalmol. 89:1442-1444, 2005.
18. Carlsen, J., Zabriskie, N., Known, Y., et al. Apparent central nervous system depression in infants after the use of topical brimonidine. Am. J. Ophthalmol. 128:255-256, 1999.
19. Enyedi, I.B., and Freedman, S.F. Safety and efficacy of brimonidine in children with glaucoma. J. AAPOS. 5:281-284, 2001.